Lumenis Extends its Range of Smart Tissue Management Solutions with the AcuPulse(TM) 40WG CO2 Laser and FiberLase(TM) CO2 Fiber

Share Article

Exhibiting at the American Academy of Otolaryngology – Head and Neck Surgery Conference

News Image
In the coming year, Lumenis will be revolutionizing the way the CO2 laser is utilized in the ENT space.

Lumenis Ltd., the world's largest medical laser company which develops, manufactures and distributes a broad range of medical lasers and sophisticated energy delivery equipment for surgical, aesthetic and ophthalmic applications, announces its participation at the American Academy of Otolaryngology – Head and Neck Surgery Conference (AAO-HNSF) in Washington, DC on September 9-12, 2012.

Lumenis will be showcasing its suite of smart CO2 tissue management solutions which include the AcuPulse 40WG, AcuPulse SurgiTouch™ 30/40, UltraPulse SurgiTouch and Digital AcuBlade, plus associated accessories. Lumenis will also preview its future solutions for otology and robotics.

The AcuPulse 40WG CO2 extends ENT practitioners’ range of surgical procedures. It assures highest control of beam delivery through the flexible fiber for smart tissue management. Three laser operation modes and three timed-exposure modes give ENT physicians the freedom to customize beam delivery.

In addition, for free beam applications, the Digital AcuBlade delivers nearly char free and shaped cutting, vaporization, and ablation to precise size and depth. “The Digital AcuBlade™ has consistently demonstrated accuracy and adaptability to challenging patient anatomy. Controlled, reproducible results reduce operating time and ensure patient safety,” says Eran Kurman, Director of ENT Global Marketing, Surgical Strategic Business Unit.

“The Digital AcuBlade is indispensable for providing optimal oncological as well as superior functional results after TLM for the treatment of larynx cancer,” says Floyd Chris Holsinger, M.D., Associate Professor, Department of Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

“In the coming year, Lumenis will be revolutionizing the way the CO2 laser is utilized in the ENT space,” said Tzipi Ozer-Armon, CEO of Lumenis. “The company has made this a priority and we look forward to further contributing to the practice of ENT and Head and Neck Surgery.”

Lumenis will be presenting at Booth #507. In addition, attendees are invited to the booth to “Meet the Experts” sessions:

Professor Marc Remacle
Dept. of ORL – Head and Neck Surgery, University Hospital of Louvain at Mont-Godinne, Belgium
Monday, September 10, 2012 1:00-2:00 pm
Tuesday, September 11, 2012 1:00-2:00 pm

Joshua S. Schindler, MD
Assistant Professor, Oregon Health and Science University, USA
Monday, September 10, 2012 2:00-3:00 pm

For more information, contact Lumenis or visit

About Lumenis
Lumenis, the world's largest medical laser company, is a global developer, manufacturer and distributor of laser and light-based devices for surgical, aesthetic and ophthalmic applications, with more than 900 employees worldwide. Lumenis has 265 registered patents, over 260 FDA clearances, an installed base of over 80,000 systems and a presence in over 80 countries. Lumenis endeavors to bring the finest state of the art technology products to the market, fulfilling the highest standards of excellence, quality and reliability, delivering premium value and service to its customers. The name Lumenis is derived from the Latin words meaning ”Light of Life” highlighting the light - the basis of our technologies - used to enhance life. For more information about Lumenis and its products, please visit:

For further information contact:

Julie Shafiki
Director, Global Marketing Communications
e-mail: julie(dot)shafiki(at)lumenis(dot)com

Lumenis® and the Lumenis logo are trademarks or registered trademarks of Lumenis.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Julie Shafiki
Lumenis LTD
Email >
Visit website